University of Washington
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Washington sits in the top decile of US sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count).
University of Washington: 1,048 sponsored US clinical trials, 156 recruiting.
University of Washington sponsors 1,048 registered US clinical trials on ClinicalTrials.gov, 156 of them currently recruiting, and 720 completed. 104 of these trials are in Phase 3-4 (later-stage) and 320 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 13 trials.
Top-decile sponsor footprint
University of Washington ranks in the top decile of sponsors by registered trial count (#30 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
720 of 816 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (88.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,048 total, page 4 of 21
Branched Thoracic Endovascular Grafts for the Treatment of Thoraco-abdominal Aortic
NCT01874197
Physician Modified Endovascular Grafts
NCT01538056
Pacific Northwest Udall Center (PANUC) Clinical Core
NCT01720810
The Parkinson's Genetic Research Study
NCT01558479
Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer
NCT01050504
Prostate Active Surveillance Study
NCT00756665
Study to Assess the Effectiveness of a Heat Risk Reduction Decision Support Platform and the Barriers and Facilitators of Its Implementation With 30 US Local Health Department Sites
NCT06971978
CBT vs. Supportive Texts for PTSD & Hazardous Drinking (Project Better Study 2)
NCT06648395
A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors
NCT06392789
MDMA-Assisted Therapy for Pathological Narcissism
NCT06565494
Adapting and Implementing a Nurse Care Management Model to Care for Rural Patients With Chronic Pain
NCT06407115
Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study
NCT05960578
Caring for Vets and Service Members: Caring Contacts for Stressed and Distressed Veterans and Service Members
NCT06136234
Narrative Writing to Promote Healthy Decisions About Alcohol During the Transition Out of High School
NCT06191861
DePTH: De-emphasize PTH
NCT06288451
MHealth Incentivized Adherence Plus Patient Navigation
NCT06027814
Optimal Timing of Computerized Cognitive Training for Older Intensive Care Unit Survivors
NCT05467410
Triple Immune Checkpoint Inhibition for Advanced or Metastatic PD-(L)1 Refractory Merkel Cell Carcinoma
NCT06056895
Hypnotic Cognitive Therapy Reduce Acute & Chronic SCI Pain in Inpatient Rehabilitation
NCT05047120
Lung Transplant READY CF 2: A Multi-site RCT
NCT06030206
Learning and Living With Wildfire Smoke
NCT06322966
Matching Adults to Treatments for Chronic Pain (MATCH) Study
NCT05699252
A Multiple Antigen Vaccine (STEMVAC) for the Treatment of Patients With Stage IV Non-Small Cell Lung Cancer
NCT05242965
Investigation of Medical Management to Prevent Episodes of Diverticulitis Trial
NCT05681559
STEMVAC in Patients With Early Stage Triple Negative Breast Cancer
NCT05455658
Emicizumab in Patients With Acquired Hemophilia A
NCT05345197
Immunogenicity of Fractional Dose of the HPV Vaccines
NCT05291871
VZV-specific Tissue Resident Memory T-cells After Shingrix Vaccination
NCT04403139
Using Technology to Optimize Collaborative Care Management of Depression in Urban and Rural Cancer Centers, SCOPE
NCT05012124
The Emergency Department Longitudinal Integrated Care
NCT05327166
The Home Blood Pressure (BP) Trial
NCT05159999
Nudges for Opioid Reduction After Major Surgery Trial
NCT04927351
Niraparib and TSR-042 for the Treatment of BRCA-Mutated Unresectable or Metastatic Breast, Pancreas, Ovary, Fallopian Tube, or Primary Peritoneal Cancer
NCT04673448
Social Interventions for Support During Treatment for Endometrial Cancer and Recurrence
NCT04930159
Isatuximab, Carfilzomib, Pomalidomide, and Dexamethasone for the Treatment of Relapsed or Refractory Multiple Myeloma
NCT04883242
Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy
NCT04692103
Understanding and Testing Recovery Processes for PTSD and Alcohol Use Following Sexual Assault
NCT04124380
An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer
NCT04777071
Effect of Testosterone Treatment on Drug Metabolism and Transport
NCT05116293
Pembrolizumab and Carboplatin for the Treatment of Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
NCT04387227
Yoga Effect on Quality of Life Study Among Patients with Idiopathic Pulmonary Fibrosis
NCT02848625
Acalabrutinib and Anti-CD19 CAR T-cell Therapy for the Treatment of B-cell Lymphoma
NCT04257578
Intradermal, Fractional Dose of HPV Vaccines:
NCT04235257
Effects of Pregnancy-associated Hormones on THC Metabolism in Women
NCT04374773
Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure
NCT04528004
Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies
NCT04205409
Motivating Campus Change Study
NCT04030325
Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors
NCT03891784
Pain & Aging: Combined Interventions for Fitness in the Community Study
NCT04099394
Comparison of Surgery and Medicine on the Impact of Diverticulitis (COSMID) Trial
NCT04095663
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 127 |
| Phase 2 | 193 |
| Phase 3 | 39 |
| Phase 4 | 65 |
What is open in the University of Washington pipeline
156 recruiting of 1,048 indexed (15% open); 720 completed (69%).
Phase mix: 104 late (III/IV) vs 320 early (I/II) (early-phase heavy).
Top condition: Depression (13 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Washington: open-pipeline peers nationwide
Peers matched on 1,048 registered trials and 15% open enrollment, not the therapeutic-area sidebar.
University of Washington sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,048 trials (± recruiting share)
- University of Wisconsin, Madison · 1,039 trials · 15% recruiting
- Bristol-Myers Squibb · 1,025 trials · 7% recruiting
- University of Florida · 1,106 trials · 15% recruiting
- University of North Carolina, Chapel Hill · 1,109 trials · 10% recruiting
Sponsors near 15% open enrollment (± trial volume)
- Dompé Farmaceutici S.p.A · 15% recruiting · 27 trials
- Vanderbilt-Ingram Cancer Center · 15% recruiting · 189 trials
- Arizona State University · 15% recruiting · 187 trials
- Georgetown University · 15% recruiting · 227 trials
Related
What to do with this University of Washington page
1,048 registered trials is a research-attention snapshot, not an endorsement of University of Washington or any single study.
- 156 of University of Washington's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of Washington studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
University of Washington pipeline card: 1,048 registered trials from official public datasets.Report a data error.